Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty

Coronary Artery Disease

Volumn 9, Issue 12, 1998, Pages 831-837

  Wohlfrom, Markus ^a   Hanke, Sybille ^a   Kamenz, Joachim ^a   Voisard, Rainer ^a   Heise, Nikolai ^a   Seibold, Wolfgang ^a   Lenz, Christina ^a   Quack, Günter ^b   Wühlfroth, Petra ^b   Hanke, Hartmut ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Antioxidants; Balloon angioplasty; Coronary artery disease; Nicanartine; Rabbits; Restenosis

Indexed keywords

ANTIBODY; ANTIOXIDANT; BROXURIDINE; CHOLESTEROL; LIPID; NICANARTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA SYNTHESIS; ELECTROSTIMULATION; IMMUNOHISTOLOGY; INFLAMMATION; MACROPHAGE; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SECONDARY PREVENTION;

EID: 0032406077     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809120-00008     Document Type: Article

References (38)

1. Hombach V, Waltenberger J, Voisard R, Hher M. Rezidivstenose nach Koronarangioplastie: Klinische, zellbiologische und molekulare Aspekte. Z Kardiol 1995; 85:5-21.
2. Halliwell B. Free radicals, reactive oxygen species and humans disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989; 70:737-757.
3. Kloner RA, Giacomelli F, Alker KJ, Hale SL, Matthews R, Bellows S. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion. Circulation 1991; 84:1758-1772.
4. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314:488-500.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
6. Austin GE, Ratcliff NB, Hollmann J, Tabei S, Philips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent secondary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6:369-375.
7. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79:1374-1387.
8. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985; 56:139-145.
9. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation 1993; 88:628-637.
10. Freyschuss A, Stiko-Rahm A, Swedenborg J, Henriksson P, Bjrkhem I, Berglund L, et al. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993; 91:1282-1288.
11. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida K. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1996; 132:23-29.
12. Tardif JC, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997; 337:365-372.
13. Wülfroth P, Bartmann A, Hopstock C, Reickel J. The new antioxidant Mrz3/124 improves lipid status and prevents oxidative damage to endothelial cells and macrophages. Bull Mol Biol Med 1994; 20:1-4.
14. Hopstock C, Robenek H, Wülfroth P: Interactions between human macrophages and low density lipoproteins: influence of antioxidants [abstract]. Eur J Cell Biol 1993; 60:57.
15. Bartmann A, Reichel JE, Wülfroth PM. Antioxidant treated endothelial cells are protected against oxidative damage. Perfusion 1994; 7:192-194.
16. Bartmann A, Engel L, Wühlfroth PM. Nicanartine und Probucol hemmen die Migration und Proliferation glatter Muskelzellen in WHHL-Kaninchen. In: Heinle H, Schulte H, Kaffarnik H (editors): Arteriosklerose Gefäße, 9. Jahrestagung der Deutschen Gesellschaft für Arterioskleroseforschung 1995. Tübingen: Deutsche Gesellschaft für Arterioskleroseforschung, 1995. pp. 305-310.
17. Wühlfroth P. Nicanartine. Drugs fut 1995; 20:572-574.
18. Betz E, Schölte W. Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 1979; 74:10-20.
19. Betz E, Hämmerle H, Strohschneider T. Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromas. Res Exp Med Berl 1985; 185:325-340.
20. Geer JC, Catsulis C, McGill HC Jr, Stron JP. Fine structure of the balloon aortic fatty streak. Am J Pathol 1968; 52:265-286.
21. Bittl JA, Sanborn TA, Tcheng JE, Siegel RM, Ellis SG. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol 1992; 70:1533-1539.
22. Hanke H, Haase KK, Hanke S, Oberhoff M, Hassenstein S, Betz E, et al. Morphological changes and smooth muscle cell proliferation after experimental excimer laser treatment. Circulation 1991; 83:1380-1389.
23. Hanke H, Oberhoff M, Hanke S, Hassenstein S, Kamenz J, Schmid KM, et al. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin. Circulation 1992; 85:1548-1556.
24. Karsch KR, Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia EJ, et al. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). J Am Coll Cardiol 1996; 28:1437-1443.
25. Strohschneider T, Hämmerle H, Betz E. Evidence for the development in phases of stenosing processes of arteries with a method of quantifying cell-kinetic reactions of smooth muscle cells in experimentally induced intima cushions [abstract]. Pflugers Arch 1988; 412:56.
26. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsh KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990; 67:651-659.
27. Falini B, De Solas I, Halverson C, Parker JW, Taylor CR. Double labeled-antigen method for demonstration of intracellular antigens in paraffin-embedded tissues. J Histochem Cytochem 1982; 30:21-26.
28. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27:1131-1139.
29. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 1984; 73:148-152.
30. Vandekerckhove J, Weber K. The complete amino acid sequence of actins from bovine aorta, bovine heart, bovine fast skeletal muscle, and rabbit slow skeletal muscle. A protein-chemical analysis of muscle actin differentiation. Differentiation 1979; 14:123-133.
31. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107:395-418.
32. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocytes/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84:2995-2998.
33. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990; 87:904-908.
34. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88:1785-1792.
35. Ku G, Doherty NS, Wolos JA, Jackson RL Inhibition by probucol of interleukin-1 secretion and its implications in atherosclerosis. Am J Cardiol 1988; 62:77B-81B.
36. Stiko-Rahm A, Hultgardh-Nilsson A, Regnstrom J, Hamsten A, Nilsson J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb 1992; 12:1099-1109.
37. Vignale SJ, Anderson HV, Chen ZQ, Pakala R, Benedict CR. Time course of cellular proliferation following angioplasty [abstract]. Circulation 1994; 90:1392.
38. Wülfroth P, Bartmann A, Engel L, Heinle H, Hopstock C, Wolfe-Coote S. Antiatherosclerotic effects of the new antioxidant Mrz3/124 in different animal models of hyperlipidemia [abstract]. Atherosclerosis 1994; 109:47.